Immunome, Inc. (IMNM)
NASDAQ·Healthcare·Biotechnology
$24.94
+8.50%
Mkt Cap $2.22B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (14 analysts)
$36.50
Range $33.00 – $40.00
Implied Upside
+46.4%
Consensus $36.50 vs current $24.94
NASDAQ·Healthcare·Biotechnology
$24.94
+8.50%
Mkt Cap $2.22B
Buy
7
Hold
0
Sell
0
Price Target (14 analysts)
$36.50
Range $33.00 – $40.00
+46.4%
Consensus $36.50 vs current $24.94